Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-ARM randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)

1990 ◽  
Vol 37 (6) ◽  
pp. 1013-1019 ◽  
Author(s):  
P.F. Bruning ◽  
J.M.G. Bonfrèr ◽  
J. Wildiers ◽  
J. Jassem ◽  
L.V.A.M. Beex ◽  
...  
1990 ◽  
Vol 27 (1) ◽  
pp. 79-80
Author(s):  
Mary E R O'Brien ◽  
E J Bayliss ◽  
Moira E Stewart ◽  
John F Smyth ◽  
Alan Rodger ◽  
...  

1998 ◽  
Vol 77 (12) ◽  
pp. 2257-2263 ◽  
Author(s):  
M Bontenbal ◽  
◽  
M Andersson ◽  
J Wildiers ◽  
G Cocconi ◽  
...  

1987 ◽  
Vol 9 (3) ◽  
pp. 217-220 ◽  
Author(s):  
Constantine S. Gennatas ◽  
Angelos Kalovidouris ◽  
George A. Paraskevas ◽  
John Kouvaris ◽  
Demetrios Trichopoulos ◽  
...  

1994 ◽  
Vol 17 (2) ◽  
pp. 175-180 ◽  
Author(s):  
Kim A. Margolin ◽  
Stephanie Green ◽  
Kent Osborne ◽  
James H. Doroshow ◽  
Steven A. Akman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document